With governments around the world debating whether to authorize COVID-19 vaccine booster doses, Moderna Inc. co-founder Noubar Afeyan envisions a time when the shot could become routine.
“Public health officials are going to have to decide if everybody should get a booster shot, he said in an interview on “The David Rubenstein Show: Peer-to-Peer Conversations that’s airing on Bloomberg TV on Wednesday.
For more coronavirus news, visit our dedicated page.
“My guess is that given enough time, we may well end up in a situation where we have, let’s say at a minimum, yearly vaccinations, just like the flu, said Afeyan, who also serves as chairman.
Afeyan said the company is hoping in the next couple of months for full US approval for its COVID-19 vaccine, which is currently authorized for emergency use. The company is testing a half-dose booster that “seems to be extremely effective, he said.
World leaders clamored for access to the vaccine before approval, Afeyan recalled. “I did get calls that I never thought I would ever get before from many, many country leaders, he said. “Nobody could do anything. Legally, the entire vaccine supply was a possession of the US government."
Afeyan’s Flagship Pioneering is investing in several technologies he said could help the world prepare for the next pandemic.
For all the latest headlines follow our Google News channel online or via the app.
“We have approaches using machine learning, AI systems, artificial intelligence systems, that are literally modeling where this virus can go, based on where it’s been already, and anticipating what variants we will see, he said. “One of the outcomes of this pandemic will be capabilities that we didn’t have before but now we know we need.”
Read more:
US to recommend COVID-19 vaccine boosters at eight months: Sources
CDC advisers vote in favor of recommending third vaccine dose for immune-impaired
Booster shot will be recommended for weakened immune systems, says Dr. Fauci
Also Read
-
US authorizes COVID-19 booster shots for those with weak immune systems
The US on Thursday authorized an extra dose of COVID-19 vaccine for people with weakened immune systems, as the country struggles to thwart the Delta ... Coronavirus -
Pfizer, Moderna seen reaping billions from COVID-19 vaccine booster market
Drugmakers Pfizer Inc, BioNTech and Moderna Inc are expected to reap billions of dollars from COVID-19 booster shots in a market that could rival the ... Coronavirus -
US to recommend COVID-19 vaccine boosters at eight months: Sources
US experts are expected to recommend COVID-19 vaccine boosters for all Americans, regardless of age, eight months after they received their second ... Coronavirus
